ClinicalTrials.gov record
Recruiting Phase 2 Interventional

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

ClinicalTrials.gov ID: NCT06908356

Public ClinicalTrials.gov record NCT06908356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 6:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients With Focal Onset or Primary Generalized Tonic-Clonic Seizures

Study identification

NCT ID
NCT06908356
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Praxis Precision Medicines
Industry
Enrollment
50 participants

Conditions and interventions

Interventions

  • 30mg PRAX-628 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 9, 2025
Primary completion
Jun 30, 2025
Completion
Jun 30, 2025
Last update posted
Apr 2, 2025

2025

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Praxis Research Site Phoenix Arizona 85032 Recruiting
Praxis Research Site Miami Lakes Florida 30116 Recruiting
Praxis Research Site Bethesda Maryland 20817 Recruiting
Praxis Research Site Chesterfield Missouri 63005 Recruiting
Praxis Research Site Hackensack New Jersey 07601 Recruiting
Praxis Research Site Middletown New York 10941 Recruiting
Praxis Research Site Round Rock Texas 78681 Recruiting
Praxis Research Site Seabrook Texas 77586 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06908356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 2, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06908356 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →